title: Omega-3 fatty acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy.
abstract: BACKGROUND
  Omega-3 fatty acids have been shown to reduce arrhythmia in animal models and people. These effects have not been studied in dogs with spontaneously occurring arrhythmia.
  
  
  OBJECTIVE
  Fish oil will reduce the frequency of ventricular arrhythmia in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy (ARVC).
  
  
  METHODS
  Twenty-four Boxers with ARVC were included in this study.
  
  
  METHODS
  Asymptomatic Boxers not receiving antiarrhythmic medications were evaluated with echocardiogram and electrocardiogram. Dogs with at least 1 ventricular premature contraction (VPC) received 24-hour ambulatory electrocardiography (AECG) recordings. Dogs with > 95 VPCs in 24 hours were randomized to 1 of 3 treatments: (1) Fish oil, 2 g; (2) Flax oil, 2 g; or (3) sunflower oil, 2 g (Control group), for 6 weeks. Investigators and owners were blinded to the treatment groups. All baseline measurements were repeated after the 6-week supplementation.
  
  
  RESULTS
  There were no differences at baseline for age, sex, blood pressure, weight, echocardiographic measurements, or VPCs. Median number of VPCs in 24 hours for all dogs was 543 (range, 96-40,063) at baseline and 193 (range, 6-14,825) after 6 weeks of supplementation. VPCs/24 h were reduced for the Fish oil group (baseline median = 397 [range, 249-10,587]; 6-week median = 162 [range, 16-3,781]; P = .02), but not for the Flax oil (P = .58) or Control (P = .48) groups.
  
  
  CONCLUSIONS
  These data suggest that fish oil, but not flax oil, supplementation for 6 weeks reduces arrhythmia in Boxers with ARVC and that it could be useful in treating this common disease. Further studies are needed to determine optimal dose and duration of treatment.
authors.affiliation: Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA.
authors.forename: Caren E
authors.initials: CE
authors.lastname: Smith
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Freeman
authors.forename: John E
authors.initials: JE
authors.lastname: Rush
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Cunningham
authors.forename: Vincent
authors.initials: V
authors.lastname: Biourge
mesh_terms: D000821:Animal Feed; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000662:veterinary*; D004032:Diet / Q000662:veterinary; D019587:Dietary Supplements; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy / Q000662:veterinary*
chemical_list: D015525:Fatty Acids, Omega-3